These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6385429)

  • 41. [Clinical pharmacology of isoniazid].
    Sokolova GV; Ivleva AIa; Ziia AV; Zeliger LR; Suvorova VI
    Probl Tuberk; 1984 Sep; (9):55-60. PubMed ID: 6504886
    [No Abstract]   [Full Text] [Related]  

  • 42. [Liver function and INH and PAS metabolism in tuberculous adolescents with side reactions to chemotherapy].
    Tytor IaN; Koropetskiĭ VI
    Vrach Delo; 1977 Jun; (6):61-4. PubMed ID: 883281
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 45. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylation phenotype profile in north Indian children with pulmonary tuberculosis.
    Seth V; Beotra A; Ray D
    Indian Pediatr; 1987 Nov; 24(11):1007-10. PubMed ID: 3450638
    [No Abstract]   [Full Text] [Related]  

  • 47. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isoniazid hepatitis: backlash of progress.
    Stead WW; Texter EC
    Ann Intern Med; 1973 Jul; 79(1):125-7. PubMed ID: 4721156
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid.
    Donald PR; Sirgel FA; Venter A; Parkin DP; Seifart HI; van de Wal BW; Werely C; van Helden PD; Maritz JS
    Clin Infect Dis; 2004 Nov; 39(10):1425-30. PubMed ID: 15546075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Genetic polymorphism of isoniazid acetylation in Chilean patients with tuberculosis].
    Ligueros M; Cruz Coke R; Neira S; Saavedra H; Kramer V; Prieto JC; Gelman M; Saavedra A; Nuñez A; Pescio S
    Rev Med Chil; 1989 Dec; 117(12):1339-43. PubMed ID: 2519370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoniazid and the liver.
    Meade GM
    Clin Pediatr (Phila); 1972 Sep; 11(9):498. PubMed ID: 5073797
    [No Abstract]   [Full Text] [Related]  

  • 52. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 55. [Value of determining plasma INH during antitubercular treatment. Retrospective analysis of 204 cases].
    Cheminat JC; Paire M; Lavarenne J; Ducarrouge C; Molina C
    Rev Fr Mal Respir; 1983; 11(6):867-73. PubMed ID: 6669797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Isoniazid hepatitis.
    Badger TL; Levy SA; Stead WW; Alonso K; Starke WR
    Ann Intern Med; 1973 Nov; 79(5):751-2. PubMed ID: 4751753
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter: Isoniazid hepatitis.
    Stein SC
    Ann Intern Med; 1974 Mar; 80(3):423-4. PubMed ID: 4816197
    [No Abstract]   [Full Text] [Related]  

  • 58. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: The isoniazid problem.
    Farer LS
    Gastroenterology; 1976 Apr; 70(4):631. PubMed ID: 1254145
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.
    Gent WL; Seifart HI; Parkin DP; Donald PR; Lamprecht JH
    Eur J Clin Pharmacol; 1992; 43(2):131-6. PubMed ID: 1425868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.